Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAReNikotin: Smoking Cessation in OAT Patients
NCT05290025Active, not recruiting
- Sponsor
- Haukeland University Hospital
- Start
- Apr 2022
- Primary completion
- Oct 2023
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nicotine patch in tobacco dependence (2 arms), sponsored by Haukeland University Hospital. Primary endpoints: Smoking cessation at 16 weeks and Smoking reduction at 16 weeks. Started Apr 2022; status: active, not recruiting.
02
Drugs
nicotine patch
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT05290025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05290025.